Danni Marquis Desjarlais, | |
6401 A St, Anchorage, AK 99518-1824 | |
(907) 632-2054 | |
Not Available |
Full Name | Danni Marquis Desjarlais |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 6401 A St, Anchorage, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093382053 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Danni Marquis Desjarlais, 6401 A St, Anchorage, AK 99518-1824 Ph: () - | Danni Marquis Desjarlais, 6401 A St, Anchorage, AK 99518-1824 Ph: (907) 632-2054 |
News Archive
Kaiser Health News staff writer Mary Agnes Carey and Eric Pianin of the Fiscal Times talk with the Kaiser Family Foundation's Jackie Judd about recent events on Capitol Hill. For instance, President Obama has scheduled a bipartisan summit for Feb. 25 to discuss ways to pass health care overhaul legislation this year.
Bobby Boyle engages in serious year-round sports training and has had his share of minor muscle injuries. When the 12-year-old athlete felt tightness in the back of his thigh while sprinting at track practice, he and his parents thought he pulled a hamstring and assumed it would heal with limited exercise time.
Some HIV/AIDS advocacy groups last week called on finance ministers from the Group of Seven industrialized nations, meeting on Friday in Germany, to fulfill commitments made by the Group of Eight industrialized nations at its 2005 summit regarding aid to Africa, including HIV/AIDS funding, South Africa's Star reports.
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
› Verified 6 days ago
Mr. Duncan R Brooks, MS, LPC. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1205 E International Airport Rd Ste 100, Anchorage, AK 99518 Phone: 907-570-6382 Fax: 888-972-3679 | |
Carolyn Michaud, OTD OTR/L Counselor Medicare: Not Enrolled in Medicare Practice Location: 4325 Laurel St Ste 102, Anchorage, AK 99508 Phone: 907-569-5660 | |
Patricia Quinn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 741 Sesame St Ste 1b, Anchorage, AK 99503 Phone: 907-406-2642 | |
Mrs. Rebecca Ann Shestakov, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6952 Cutty Sark St, Anchorage, AK 99502 Phone: 907-982-5562 | |
Parinita Shetty, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7440 Creekside Center Dr, Anchorage, AK 99504 Phone: 907-279-9640 | |
Tau Vaaia, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1709 Bragaw St, Anchorage, AK 99508 Phone: 907-562-5340 | |
Katie Ogin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2600 Cordova St, Anchorage, AK 99503 Phone: 907-279-9640 |